Tarsus Pharmaceuticals, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Tarsus Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $200K, unchanged year-over-year.
  • Tarsus Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $710K, a 34.2% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Depreciation for 2023 was $744K, a 129% increase from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Depreciation for 2022 was $325K, a 8.33% increase from 2021.
  • Tarsus Pharmaceuticals, Inc. annual Depreciation for 2021 was $300K, a 200% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $744K +$419K +129% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $325K +$25K +8.33% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $300K +$200K +200% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $100K +$63K +170% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $37K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.